High-Purity 1-(Piperidin-4-yl)-1,3-dihydrobenzoimidazol-2-one CAS 20662-53-7 for Pharmaceutical Intermediates

As a leading manufacturer and supplier in China, we offer 1-(Piperidin-4-yl)-1,3-dihydrobenzoimidazol-2-one (CAS 20662-53-7), a critical pharmaceutical intermediate vital for drug discovery and development. Secure your supply chain with our high-quality, reliably sourced material. Get a quote and sample today.

Get a Quote & Sample

Key Advantages for Your Research

Exceptional Purity and Quality

With a strict quality control process, we ensure that every batch of 1-(Piperidin-4-yl)-1,3-dihydrobenzoimidazol-2-one meets the highest standards, making it a dependable choice for your critical pharmaceutical intermediate needs. When you purchase from us, you're investing in reliability.

Facilitates CNS Drug Discovery

This heterocyclic compound is instrumental in the synthesis of potential dopamine receptor modulators and serotonin antagonists. Leverage this key intermediate in your drug discovery programs for neurological applications, and inquire about bulk purchase options.

Streamlined Sourcing and Supply

As a dedicated manufacturer and supplier in China, we simplify your procurement process. Our efficient logistics ensure timely delivery, and we are ready to provide a competitive price quote for your commercial requirements of this vital pharmaceutical intermediate.

Applications in Pharmaceutical Development

Pharmaceutical Synthesis

Utilized as a crucial building block in the multi-step synthesis of various pharmaceutical compounds, particularly those with potential neurological activity.

Drug Discovery

Essential for medicinal chemists in exploring new molecular entities targeting CNS disorders, including potential therapies for Parkinson's disease.

Research & Development

A valuable reagent for academic and industrial R&D laboratories conducting studies on heterocyclic chemistry and novel drug development.

Custom Synthesis Projects

Can be integrated into custom synthesis projects requiring specialized heterocyclic scaffolds for novel therapeutic agents.